EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated Anti-Cytomegalovirus IgG Levels Are Associated with Higher Erythropoiesis-Stimulating Agent Dose in Transplant-Listed Patients with End-Stage Kidney Disease

Alexander Jerman iD, Miha Arnol iD, Vanja Peršič

Journal of Clinical Medicine · 02.11.2026 · 15 (21) · 8541

DOI: 10.3390/jcm15218541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.11.2026. Verfasst von Alexander Jerman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ljubljana University Medical Centre, The Slovenian Research and Innovation Agency, University Medical Center Ljubljana.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CMV seropositivity has been associated with increased epoetin demand in patients with end-stage kidney disease (ESKD) undergoing kidney replacement therapy (KRT). However, the available data remain inconclusive.

Methods

In this single-center retrospective study we screened adult kidney transplant candidates with dialysis-dependent ESKD and whose CMV serostatus was known. Baseline patient characteristics and erythropoiesis-stimulating agent (ESA) prescription data were evaluated. Multivariate analysis was performed to determine whether CMV seropositivity or anti-CMV immunoglobulin levels are associated with more frequent ESA prescription and higher standardized ESA weekly dose.

Results

A total of 198 patients were included, with a median age of 51 years; 31% were female. The majority of patients (73%) were treated with hemodialysis, and the median dialysis vintage was 1 year. ESA therapy was prescribed to 77% of patients, with a standardized median weekly dose of 61 units per kilogram of body weight. CMV seropositivity was identified in 79% of patients and was associated with older age, longer dialysis vintage, higher serum CRP and ferritin levels, and lower serum total iron-binding capacity. In adjusted regression models, ESA prescription rate and ESA weekly dose were not associated with CMV seropositivity. Conversely, higher ESA weekly dose was associated with CMV IgG levels in the 5th quintile (both p < 0.001) after adjustment for hemoglobin levels and body iron stores.

Conclusion

CMV seropositivity was not associated with an increased likelihood of ESA prescription among transplant-listed individuals with ESKD. In a fully adjusted regression model, however, standardized weekly ESA dose was significantly higher in individuals with anti-CMV IgG levels in the highest quintile. Further studies are warranted to determine the true nature of these observations. If confirmed, it will be important to clarify whether elevated anti-CMV IgG levels reflect underlying immune dysregulation, or conversely, whether CMV reactivations contribute both to increased IgG levels and to ESA hyporesponsiveness.

Schlagwörter

Stichwörter der Autor:innen

cytomegaloviruserythropoietinkidney diseaserenal anemia

Autor:innen und Institutionen

  • Department of Nephrology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
  • Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
  • Sferogen, 5270 Ajdovscina, Slovenia.

ORCID-Profile: Alexander Jerman, Miha Arnol

Förderung

  • Ljubljana University Medical Centre
  • The Slovenian Research and Innovation Agency
  • University Medical Center Ljubljana

Zitieren

APA

Jerman, A., Arnol, M., & Peršič, V. (2026). Elevated Anti-Cytomegalovirus IgG Levels Are Associated with Higher Erythropoiesis-Stimulating Agent Dose in Transplant-Listed Patients with End-Stage Kidney Disease. Journal of Clinical Medicine, 15(21), 8541. https://doi.org/10.3390/jcm15218541

Vancouver

Jerman A, Arnol M, Peršič V. Elevated Anti-Cytomegalovirus IgG Levels Are Associated with Higher Erythropoiesis-Stimulating Agent Dose in Transplant-Listed Patients with End-Stage Kidney Disease. Journal of Clinical Medicine. 2026;15(21):8541. doi:10.3390/jcm15218541

BibTeX
@article{Jerman2026,
  author = {Jerman, Alexander and Arnol, Miha and Peršič, Vanja},
  title = {Elevated Anti-Cytomegalovirus IgG Levels Are Associated with Higher Erythropoiesis-Stimulating Agent Dose in Transplant-Listed Patients with End-Stage Kidney Disease},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8541},
  doi = {10.3390/jcm15218541}
}
Kostenlos starten →